James Read

Royal Surrey NHS Foundation Trust

Papers

1

Total Citations

13

H-Index

1

About

James Read is a leading gynaecological oncology surgeon whose work centres on advancing minimally invasive surgical techniques for complex pelvic malignancies. His major contribution lies in demonstrating the feasibility and safety of laparoscopic and robotic approaches for pelvic exenteration—a radical procedure traditionally performed via open surgery. In his landmark 2022 case series, Read and his team reported on 13 patients undergoing minimally invasive pelvic exenteration for gynaecological cancer, achieving comparable oncological outcomes with reduced morbidity, shorter hospital stays, and faster recovery. This study, which has garnered 13 citations, has helped shift the paradigm toward less invasive treatment options for advanced disease. Read’s research also encompasses surgical innovation, patient-reported outcomes, and the integration of enhanced recovery pathways. His work has been recognised with invitations to present at international meetings and has influenced clinical guidelines. By challenging conventional surgical dogma, Read is improving quality of life for women facing the most aggressive gynaecological cancers, making him a respected voice in the field of gynaecological oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive pelvic exenteration for gynaecological malignancy: A single-centre case series and review of the literature
13 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Royal Surrey NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago